Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.

Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.

Item
http://www.wikidata.org/entity/Q37913349
Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.Safety of ACE inhibitor therapies in patients with chronic kidney disease.Labetalol for hypertension in pregnancy.Taking angiotensin-converting enzyme inhibitors during pregnancy: is it safe?Neonatal acute kidney injury following Valsartan exposure in utero: report of two cases.Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.Hypertension in pregnancy: natural history and treatment options.Gender Differences in Cardiovascular Drugs.Gender differences in the effects of cardiovascular drugs.Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations.Are angiotensin-converting enzyme inhibitors and angiotensin 2 receptor blockers teratogenic?Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study.Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter].
P2860

Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.

Item
http://www.wikidata.org/entity/Q37913349
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.
@en
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.
@nl
type
label
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.
@en
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.
@nl
prefLabel
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.
@en
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers
@en
P2093
P2860
P304
P31
P356
10.3109/01443615.2011.579197
P433
P478
P50
P577
P698
P921